These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 4719844)
41. Magnesium levels of plasma, erythrocyte and urine in patients with diabetes mellitus. Fujii S; Takemura T; Wada M; Akai T; Okuda K Horm Metab Res; 1982 Mar; 14(3):161-2. PubMed ID: 7068108 [No Abstract] [Full Text] [Related]
42. [Risk in uncontrolled diabetes in relation to the manifestations and prognosis of diabetic retinopathy]. Dimoski N; Tomić Z Med Pregl; 1988; 41(1-2):12-5. PubMed ID: 3185368 [No Abstract] [Full Text] [Related]
44. Aspects of growth hormone control in diabetes. Hyer SL; Kohner EM Aust N Z J Ophthalmol; 1990 Feb; 18(1):33-9. PubMed ID: 2113400 [TBL] [Abstract][Full Text] [Related]
47. [Frequency, severity and forms of manifestation of diabetic retinopathy in relation to the status of compensation for disordered metabolism in diabetes mellitus]. Lekishvili VP; Chkoniia EA; Bogatyreva ShI; Sulkhanishvili IZ Probl Endokrinol (Mosk); 1974; 20(3):20-3. PubMed ID: 4281480 [No Abstract] [Full Text] [Related]
48. Levodopa-stimulated growth hormone secretion and diabetic retinopathy. Holland PM; Landers MB; Lebovitz HE; Wolbarsht ML Am J Ophthalmol; 1976 Oct; 82(4):612-8. PubMed ID: 970425 [TBL] [Abstract][Full Text] [Related]
49. Immunoreactive growth hormone in plasma and urine in long term insulin treated diabetics in relation to diabetic retinopathy. Hanssen KF Acta Endocrinol (Copenh); 1974 Jan; 75(1):64-74. PubMed ID: 4406482 [No Abstract] [Full Text] [Related]
51. [Clinical significance of evaluation of lipid peroxides in diabetes mellitus]. Yabe R; Mizuno K; Fukuchi S Nihon Rinsho; 1990 Dec; 48 Suppl():365-9. PubMed ID: 2086910 [No Abstract] [Full Text] [Related]
52. Ophthalmoscopic findings and changes in hormonal and metabolic parameters in "protodiabetes". Pfeiffer M; Birk J; Faulhaber JD; Laube H; Pal S; Rothenbuchner G; Schleyer M; Schroedes KE Adv Metab Disord; 1973; 2():Suppl 2:317-22. PubMed ID: 4352672 [No Abstract] [Full Text] [Related]
53. [Growth hormone and diabetic microangiopathy]. Passa P Sem Hop; 1972 Dec; 48(50):3329-32. PubMed ID: 4349844 [No Abstract] [Full Text] [Related]
54. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Gerich JE Scand J Gastroenterol Suppl; 1986; 119():154-7. PubMed ID: 2876500 [TBL] [Abstract][Full Text] [Related]
55. Secondary diabetic retinopathy in chronic pancreatitis. Maekawa N; Ohneda A; Kai Y; Saito Y; Koseki S Am J Ophthalmol; 1978 Jun; 85(6):835-40. PubMed ID: 677211 [TBL] [Abstract][Full Text] [Related]
56. Serial changes in glucose utilization and insulin and growth hormone secretion in acute cerebrovascular disease. Huff TA; Lebovitz HE; Heyman A; Davis L Stroke; 1972; 3(5):543-52. PubMed ID: 4652729 [No Abstract] [Full Text] [Related]
57. Influence of weight upon serum insulin and the serum growth hormone responses of male offspring of two diabetic parents. Soeldner JS; Sonksen PH; Gleason RE Adv Metab Disord; 1970; 1():Suppl 1:297+. PubMed ID: 5446898 [No Abstract] [Full Text] [Related]
58. Diabetes mellitus: clinical features in 404 Ethiopians. Lester FT; Abdulkadir J; Larson D; Quana'a P Ethiop Med J; 1976 Oct; 14(4):185-98. PubMed ID: 1032918 [No Abstract] [Full Text] [Related]
59. Effect of smoking on diabetic retinopathy. Aziz S; El-Gengehy MT; Othman A; El Hofy OA; Aly MA; Said E J Egypt Med Assoc; 1978; 61(11-12):743-50. PubMed ID: 556075 [No Abstract] [Full Text] [Related]
60. Possible role of insulin deficiency and growth hormone in severe retinopathy. Jennings PE; Odugbesan O; Fetcher J; Barnett AH Lancet; 1985 Aug; 2(8453):501. PubMed ID: 2863521 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]